Clinuvel Pharmaceuticals Limited (CUV) is a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders. CUV’s lead compound is SCENESSE (afamelanotide), a drug targeting erythropoietic protoporphyria (EPP).
Clinuvel Pharmaceuticals Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.clinuvel.com.
The most recent CUV dividend details are as follows: ex-dividend date: 05/09/2023. This dividend is 5 cents. Franking percentage is: 100%. The payment date for this dividend is 20/09/2023.
Based on our analysis, from 2010, Clinuvel Pharmaceuticals Limited pays dividend 5 times. Total dividend is 16 cents. Average dividend is 3.2 cents. Maximum dividend is 5 cents while minimum dividend is 2 cents. We believe using more recent dividend history can provide better dividend analysis for a company.
You can also check out dividend history for similar stocks in the same sector as follows:
CUV Dividend Dates
Please click the table header to sort the data.
| Dividend | Franking | Ex-Dividend Date | Payment Date |
|---|---|---|---|
| 5c | 100% | 05/09/2023 | 20/09/2023 |
| 4c | 100% | 06/09/2022 | 21/09/2022 |
| 2.5c | 0% | 02/09/2021 | 17/09/2021 |
| 2.5c | 0% | 04/09/2019 | 19/09/2019 |
| 2c | 0% | 21/09/2018 | 08/10/2018 |
Dividend Growth Chart
A picture is better than thousands of words. The following chart shows you CUV dividend growth over the years